Amyotrophic Lateral Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
In silico analysis of PFN1 related to amyotrophic lateral sclerosis.
|
31216283 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations of Profilin-1 Associated with Amyotrophic Lateral Sclerosis Promote Aggregation Due to Structural Changes of Its Native State.
|
26226631 |
2015 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In summary, we conclude that genetic variations in UBQLN2 and PFN1 in a predominantly Flanders-Belgian cohort of FTLD and ALS patients are extremely rare.
|
23312802 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A set of missense mutations in the gene encoding profilin-1 has been linked to the onset of familial forms of ALS (fALS), also known as Lou Gehrig's disease.
|
29760185 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Although profilin 1 C71G was only expressed during development, adult mice presented with some ALS-associated pathology and motor symptoms.
|
31611772 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In a German ALS family we identified the novel heterozygous PFN1 mutation p.Thr109Met, which was absent in controls.
|
23141414 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Regardless, the recent finding that additional RNA-binding proteins may also cause ALS, and the observation that TDP-43 aggregation remains a core feature in all of the recently identified genetic forms of ALS (C9ORF72, VCP, UBQLN2, and PFN1), underscores the central role of TDP-43 and RNA metabolism in ALS and FTLD.
|
23041957 |
2012 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this study, we investigated the mutation spectrum of PFN1 in Chinese patients with ALS.
|
23428184 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Given this genetic interaction and recent evidence linking stress granule dynamics to ALS pathogenesis, we hypothesized that profilin 1 might also associate with stress granules.
|
24920614 |
2014 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Impaired actin binding is a common denominator of several PFN1 mutations associated with amyotrophic lateral sclerosis, although further mechanisms may also contribute to the death of motor neurons.
|
26572741 |
2015 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Amyotrophic lateral sclerosis: an update on recent genetic insights.
|
24085347 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
PFN1 is a small actin-binding protein that promotes formin-based actin polymerization and regulates numerous cellular functions, but how the mutations in PFN1 cause ALS is unclear.
|
27681617 |
2016 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Cells expressing PFN1 mutants contain ubiquitinated, insoluble aggregates that in many cases contain the ALS-associated protein TDP-43.
|
22801503 |
2012 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we combine a screen of a new cohort of 383 ALS patients with multiple-sequence datasets to refine estimates of the ALS and FTD risk associated with PFN1 E117G.
|
24309268 |
2014 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We conclude that mutations in PFN1 are not a common cause for ALS/FTLD in France.
|
23182804 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
No mutations were identified in our cohort suggesting that PFN1 gene mutations are a very rare cause of familial ALS among patients with predominantly European ancestry.
|
23062600 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we investigated direct effects of profilin on microtubule dynamics and whether ALS-linked mutations in PFN1 disrupt such functions.
|
29129529 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that PFN1 mutations and pathology are not common in an Australian ALS cohort of predominantly European ancestry.
|
23635659 |
2013 |
Keloid
|
0.300 |
Biomarker
|
disease |
CTD_human |
Comparative proteomic analysis between normal skin and keloid scar.
|
20128793 |
2010 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Squamous cell carcinoma of esophagus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
|
21517111 |
2011 |
Glomerulonephritis, Membranoproliferative
|
0.200 |
Biomarker
|
disease |
RGD |
Enhanced glomerular profilin gene and protein expression in experimental mesangial proliferative glomerulonephritis.
|
8651905 |
1996 |
Depressive disorder
|
0.110 |
Biomarker
|
disease |
BEFREE |
The ALS-18 was significantly associated with concurrent measures of depression and difficulties in emotion regulation.
|
29651267 |
2018 |
Depressive disorder
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|